Hyperfine (HYPR) Income from Continuing Operations (2021 - 2026)
Hyperfine (HYPR) reported Income from Continuing Operations of 8623000.0 for Q1 2026, up 8.44% on a YoY basis from 7951768.73 in Q1 2025, and down 45.86% quarter-over-quarter from 5912000.0 in Q4 2025.
Hyperfine (HYPR) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Hyperfine has reported Income from Continuing Operations for 6 years, with the latest figure at 8623000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 8.44% year-over-year to 8623000.0; the trailing twelve-month figure through Mar 2026 stood at 34779000.0 (up 13.68% YoY), and the FY2025 full-year result was 35574000.0, up 12.64% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 8623000.0, down from 5912000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 5912000.0 in Q4 2025, with the low at 23775000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 11901117.65 across 5 years, with a median of 10637000.0 in 2023.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 205.04% — and 2023, when it surged 54.07%.
- Hyperfine's Income from Continuing Operations stood at 13059000.0 in 2022, then gained by 18.19% to 10684000.0 in 2023, then rose by 2.75% to 10390000.0 in 2024, then surged by 43.1% to 5912000.0 in 2025, then slumped by 45.86% to 8623000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 8623000.0 (Q1 2026), 5912000.0 (Q4 2025), and 11019000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | -8.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.62 Mn |
| Dec 31, 2025 | -5.91 Mn |
| Sep 30, 2025 | -11.02 Mn |
| Jun 30, 2025 | -9.23 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -10.33 Mn |
| Jun 30, 2024 | -10.16 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Dec 31, 2023 | -10.68 Mn |
| Sep 30, 2023 | -10.76 Mn |
| Jun 30, 2023 | -10.64 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -13.06 Mn |
| Sep 30, 2022 | -13.17 Mn |
| Jun 30, 2022 | -23.16 Mn |
| Mar 31, 2022 | -23.78 Mn |
| Dec 31, 2021 | -26.09 Mn |
| Sep 30, 2021 | -16.39 Mn |
| Jun 30, 2021 | -14.58 Mn |